Cardiovascular Diseases

Left Ventricular Size and Mortality Risk in Heart Failure

A Chinese nationwide study of 273,921 patients hospitalized with heart failure (HF) found a U-shaped association between left ventricular end-diastolic diameter (LVEDD) and mortality, with both abnormally small and abnormally large left ventricles independently associated with higher all-cause mortality. Using data from the Chinese Cardiovascular Association Database–Heart Failure Center Registry, this multicenter cohort included patients from 723 centers across 31 provincial-level administrative regions in mainland China between January 2018 and May 2022. Compared with patients with normal LV size, those with a small LV had a 32% higher adjusted risk of all-cause mortality (adjusted HR, 1.32), while those with a large LV had a 38% higher risk (adjusted HR, 1.38); a similar U-shaped relationship was observed for cardiovascular mortality. Sex-specific optimal LVEDD thresholds were 47 mm for men and 43 mm for women, and each 1-mm deviation from these thresholds was associated with a significant increase in mortality risk. The findings remained consistent across prespecified subgroups, with LVEDD indexed to body surface area, and in extensive sensitivity analyses, including competing-risk and complete-case analyses. These results suggest that both unusually small and unusually large left ventricular size are markers of increased mortality risk in HF, supporting incorporation of LV size into routine risk stratification and personalized HF management. Source: https://jamanetwork.com/

hyangiu

Recent Posts

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

22 hours ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

2 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

3 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

3 days ago

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

6 days ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

6 days ago

This website uses cookies.